Slovo úvodem

doc. MUDr. Miroslav Hanuš, CSc.

Urol. praxi, 2011; 12(3): 143  

Treatment of non-neurogenic voiding dysfunction in men

MUDr.Květoslav Novák, FEBU

Urol. praxi, 2011; 12(3): 147-151  

Treatment of non-neurogenic voiding dysfunction in men is focused on lower urinary tract symptoms. Their prevalence increases with age concernig men with bening prostatic hyperplasia and overactive bladder. The most frequently used drug-groups are α-blockers, 5α-reductase inhibitors and antimuscarinics. Combined therapy have a special indications – are explained in overview.

Treatment agorithm in metastatic renal cell carcinoma

MUDr.Hana Študentová

Urol. praxi, 2011; 12(3): 152-157  

Development of targeted therapy has entirely changed the treatment strategy of metastatic renal cell carcinoma since targeted therapy has become the standard of care in this setting. Currently, there are two major groups of targeted agents: vascular endothelial growth factor (VEGF) inhibitors and inhibitors of VEGF receptor (VEGFR), the latter group consists of mTOR inhibitors. Their efficacy was confirmed in clinical trials resulting in their approval in clinical practise with well-defined indications and safety profile. The cytoreductive nephrectomy remains an important part of the treatment strategy, if clinically indicated.

Bone metastasis in prostate cancer and other urological malignancies - 1st part

MUDr.Otakar Čapoun

Urol. praxi, 2011; 12(3): 158-163  

Metastatic prostate cancer is a serious disease with the only palliative therapy possible. In almost all cases castration-resistant prostate cancer patients will die with bone metastasis. Skeletal lesions are associated with greater morbidity and pain, that result in the patients’ lower quality of life. Novel therapeutic methods utilize results of the research of metastatic process pathofysiology, especially of factors affecting formation and progression of bone lesion. Laboratory markers together with imaging methods contribute to the clinical staging and treatment response assessment, and are used in mathematical models for the evaluation...

Urinary tract infection - and what about men ?

MUDr.Petr Macek, Ph.D., FEBU

Urol. praxi, 2011; 12(3): 164-168  

Infection of the lower urinary tract and genital tract in men such as urethritis, prostatitis, epididymitis, orchitis and cystitis are still current, despite they do not pose the greatest share of urological problematic. Every urologist should be familiar with the problems, to be able to get oriented among the specifics of antibiotic treatment depending on the type of disease as well as should be aware of the need for complex urinary tract investigation in selected cases, and also investigation and treatment of the partner in sexually acquired diseases.

Hormonal treatment in radiation therapy for locally advanced prostate cancer

MUDr.Jana Katolická, Ph.D.

Urol. praxi, 2011; 12(3): 170-172  

Hormonal therapy with radiotherapy or following radiotherapy for all patients with locally advanced prostate cancer improved overall survival, disease-specific survival and disease-free survival.

Diagnosis and treatment of urolitiasis

MUDr.Aleš Petřík, Ph.D.

Urol. praxi, 2011; 12(3): 173-179  

Ultrasonography is basic screening method in diagnostics of urinary stones. non-contrast CT is superior to IVU due to higher sensitivity and specificity. Contrast study is optional in cases of planning of renal stones removal. Benefit of the CT study should be compared to radiation hazard. Conservative treatment of ureteric stones is indicated as a primary method. Using of α1 blockers increase probability of stone passage and accelerates the spontaneous passage of the stone. SWL and ureteroscopy are equal methods of stone removal of all locations of ureteric stones. Ureteroscopy is more effective, but more invasive. SWL is indicated in...

Komentář k článku doc. Těšínského „Nutriční a metabolické aspekty perioperační péče u cystektomie“ Urol. Praxi, 2011; 12(2): 114-116.

MUDr. Kateřina Bartoníčková

Urol. praxi, 2011; 12(3): 191  

Wobenzym.

MUDr.Miroslav Förstl, Bc.Miroslava Förstlová, doc.MUDr.Olga Ryšková, CSc., MUDr.Ivo Kalousek, Ph.D., MUDr.Pavel Navrátil, CSc.

Urol. praxi, 2011; 12(3): 180-182  

Enzyme therapy for urogenital infections with Chlamydia trachomatis The aim of the paper is to publish the results of the effect of antibiotic therapy (ATB) alone as well as of its combination with systemic enzyme therapy in acute uncomplicated urogenital infections with Chlamydia trachomatis. We have previously published the results of the treatment with azithromycin alone (AZT: 1 × 500 mg/day for 3 days) and of the same treatment in combination with Wobenzym (W: 3 × 5 tablets/day for 14 days). Now, we present the results of our second study where virtually the same was investigated, i. e. a combination of the same enzyme therapy with another...

Renal actinomycosis

MUDr.Ján Čičila, MUDr.Aleš Petřík, Ph.D.

Urol. praxi, 2011; 12(3): 183-184  

Affecting of kidney by actinomycosis is very rare. Only a few cases of affecting urogenital system have been published. The differential diagnosis of renal actinomycosis this is diagnostics difficult due to rare incidence of the disease. The case report of patient, referred by district department of pulmonary disease, as advanced renal tumour, is presented. The nephrectomy was performed, due to septic status of the patient. Histological findings revealed actinomycosis of the kidney. Early diagnosis and targeted antibiotic therapy has the key role in the treatment of disease.

Laparoscopy - care of instruments

Jiřina Černá

Urol. praxi, 2011; 12(3): 187-188  

The article briefly describes the early era of laparoscopic surgeries and the care of laparoscopic instruments.

Kontrastní látky s obsahem gadolinia a nefrogenní systémová fibróza

MUDr.Jana Mladá, MUDr.Petra Vacková

Urol. praxi, 2011; 12(3): 189-190  

How to perform hand hygiene?

MUDr.Dana Hedlová

Urol. praxi, 2011; 12(3): 185-186  

There are a number of factors that can increase the risk of acquiring healthcare associated infections, but high standards of infection control practice minimise the risk of occurrence. In healthcare settings, hand hygiene can prevent potentially fatal infections from spreading from patient to patient and from patient to healthcare worker and vice-versa. Hand hygiene is one of the most cost-effective measures in control and prevention of infections.

Autodidaktický test 3/2011

Urol. praxi, 2011; 12(3): 193-194